Colorectal Research; VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark P...
Colorectal Research; VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
The CE mark performance evaluation will be led by Priv-Doz. Dr. Stefan Holdenrieder at the Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn. His team will use VolitionRx's NuQ(R) kits as a confirmatory trial on patient samples from VolitionRx's ongoing collaboration with Hvidovre Hospital, Denmark, for CE regulato...
Alternative Titles
Full title
Colorectal Research; VolitionRx Extends Agreement With University Hospital Bonn to Include CE Mark Performance Evaluation
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1519986511
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1519986511
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
